Participate

• Call for Abstracts for National Lymphedema Conference

  The call for abstracts is open for the 2021 National Lymphedema Conference! The Canadian Lymphedema Framework (CLF) is accepting abstracts for either an oral or poster presentation at the conference, which will take place virtually on December 3-4, 2021. The CLF welcomes abstracts from all stages of the research process, including study protocols, feasibility and pilot studies, and clinical case series. However, submissions are not limited to research-based abstracts. If you have a special interest in a topic that is important or have a special case study, the CLF encourages you to submit an abstract to share knowledge with your colleagues.

  Key Dates

  April 15 - Call for English abstracts officially opens April 30 - Communication and Call for French abstracts officially opens August 1 - Deadline for abstract submissions September 15 - Notification of accepted abstractsParticipate Now

• 2021 CADTH Symposium: Call for Abstract Reviewers

  The 2021 CADTH Symposium is being held virtually on November 2, 3, and 4, 2021. CADTH is looking for volunteers to review the abstracts submitted for presentation at this year’s conference. Volunteer reviewers help CADTH shape an engaging and well-rounded program. This is a great opportunity for individuals at all career levels, including students, to get involved in the 2021 Symposium. To join the Abstract Review Committee, simply complete the questionnaire by Tuesday, June 22, 2021. The call for abstracts for the symposium is also open! Abstracts must be submitted by Tuesday, June 22, 2021.Participate Now

• Modernizing Health Canada’s Clinical Trials Framework

  Health Canada, the federal regulator for drugs and health products, is proposing to modernize the way it regulates clinical trials. Clinical trials are required for all kinds of health products, from prescription medications to medical devices, in order to ensure they are safe and effective. Health Canada regulates clinical trials to make sure that participants are safe, ethical principles are followed, and the results of the trial are reliable. Health Canada is in the process of consulting with stakeholders – including all interested Canadians – about the proposed changes to the regulations. For more information, see the Clinical Trials Regulatory Modernization Initiative on the Health Canada website.

  How can you participate in these consultations?

  First, read the consultation paper: it introduces the proposals for transforming Canada’s regulatory framework for clinical trials related to human drugs, medical devices, and natural health products. Then, you can fill out the accompanying questionnaire. You may also submit written input by email. Finally, Health Canada is also conducting a series of webinars with specific groups of stakeholders. This series includes a webinar discussion with patients and patient groups, taking place on June 21st, 2021. If you would like an invitation to this webinar, contact jonathan.wu@canada.ca.Participate Now

• Canadian Organization for Rare Disorders looking for people to join their Board of Directors

  The Canadian Organization for Rare Disorders is looking for passionate, creative, committed, qualified people to join our Board of Directors for the 2021-2024 term to help guide our organization to meet the needs of the rare disease community. CORD wishes to invite interested candidates to submit their application to join the Board of Directors for 2021-2024 term. We are particularly interested in hearing from individuals whose experience and skill set includes a combination of the following:

  • Finance, accounting
  • Grant writing
  • Fundraising and special events
  • Health policy development
  • Public relations, communications
  • Advocacy on a provincial/federal level
  • Nonprofit, governance, management, administration experience

  Application Deadline: June 10, 2021

  Please submit your application to: https://www.surveymonkey.com/r/PKF9GMC

  Canadian Organization for Rare Disorders
  151 Bloor St W, Suite 600
  Toronto, ON M5S 1S4
  T: (416) 969-7464
  F: (416) 969-7420
  E: info@raredisorders.caParticipate Now